(Q40095201)

17 September 2017

Site-specific effects of peptide lipidation on beta-amyloid aggregation and cytotoxicity (English)

1 reference

17 September 2017

Adrienne Boire

2

0 references

author name string

Isam M Qahwash

1

1 reference

17 September 2017

Jennifer Lanning

3

1 reference

17 September 2017

Thomas Krausz

4

1 reference

17 September 2017

Peter Pytel

5

1 reference

17 September 2017

Stephen C Meredith

6

1 reference

17 September 2017

language of work or name

English

0 references

publication date

9 August 2007

1 reference

Journal of Biological Chemistry

17 September 2017

1 reference

17 September 2017

282

1 reference

17 September 2017

51

1 reference

17 September 2017

36987-36997

1 reference

Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease

17 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

The molecular pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Age-dependent change in the levels of Abeta40 and Abeta42 in cerebrospinal fluid from control subjects, and a decrease in the ratio of Abeta42 to Abeta40 level in cerebrospinal fluid from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Promotion of oxidative lipid membrane damage by amyloid beta proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Small molecule oxidation products trigger disease-associated protein misfolding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Metabolite-initiated protein misfolding may trigger Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

(E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Evidence of oxidative stress in the neocortex in incidental Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases a

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Protein adducts generated from products of lipid oxidation: focus on HNE and one.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Aging and oxidative stress in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Basic aspects of the biochemical reactivity of 4-hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Reactions of 4-hydroxynonenal with proteins and cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Molecular structure of amyloid fibrils: insights from solid-state NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Oxidized LDL, a critical factor in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Aggregation kinetics of extended porphyrin and cyanine dye assemblies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Insertion of Alzheimer's A beta 40 peptide into lipid monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Lipid binding inhibits alpha-synuclein fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Low density lipoprotein undergoes oxidative modification in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Role of oxidative modifications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Early synergy between Abeta42 and oxidatively damaged membranes in promoting amyloid fibril formation by Abeta40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Mechanisms of oxysterol-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Oxidized lipoproteins and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Oxidized low-density lipoprotein-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702146200

21 January 2018

Identifiers

DOI

10.1074/JBC.M702146200

1 reference

17 September 2017

1 reference